Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine versus dexamethasone versus control for respiratory complications after adeno-tonsillectomy
IRCT20200506047322N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine and dexamethasone (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Respiratory complications after surgery and Intubation time. Started Oct 2018; status: completed.
02
Drugs
lidocainedexamethasone
Beyond the preview
Go deeper on IRCT20200506047322N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200506047322N1.